Search

Search Constraints

You searched for: Author/Creator Subbiah, V

Search Results

1. 105PDetection and clearance of RET variants in plasma cell free DNA (cfDNA) from patients (pts) treated with LOXO-292. (23rd October 2018)

2. 363OTreatment with pralsetinib (formerly BLU-667), a potent and selective RET inhibitor, provides rapid clearance of ctDNA in patients with RET-altered non-small cell lung cancer (NSCLC) and medullary thyroid cancer (MTC). (24th November 2019)

3. 71OPhase I extension study of ETC-159 an oral PORCN inhibitor administered with bone protective treatment, in patients with advanced solid tumours. (25th November 2018)

5. Selective RET kinase inhibition for patients with RET-altered cancers. (18th April 2018)